In this Q&A, Monica Gandhi, MD, MPH, discusses interventions to address the health care disparities that exist along the care continuum for certain patient populations who are at-risk for HIV...
In this Q&A, Monica Gandhi, MD, MPH, discusses interventions to address the health care disparities that exist along the care continuum for certain patient populations who are at-risk for HIV...
In this Q and A, Rebecca Sherman, AuD, answers our questions on the importance of monitoring hearing as a patient gets older, how hearing loss affects the brain, and the link between untreated hearing loss...
In this Q and A, Rebecca Sherman, AuD, answers our questions on the importance of monitoring hearing as a patient gets older, how hearing loss affects the brain, and the link between untreated hearing loss...
In this Q&A, Sara Reece, PharmD, CDCES, discusses the use of GLP-1 agonists and SGLT-2 inhibitors to improve cardiovascular and renal outcomes in patients with type 2 diabetes.
In this Q&A, Sara Reece, PharmD, CDCES, discusses the use of GLP-1 agonists and SGLT-2 inhibitors to improve cardiovascular and renal outcomes in patients with type 2 diabetes.
In this Q&A, Sara Reece, PharmD, CDCES, discusses the use of GLP-1 agonists and SGLT-2 inhibitors to improve cardiovascular and renal outcomes in patients with type 2 diabetes.
In this Q&A, Sara Reece, PharmD, CDCES, discusses the use of GLP-1 agonists and SGLT-2 inhibitors to improve cardiovascular and renal outcomes in patients with type 2 diabetes.
Dr Jonathan Repple
In this Q&A, Jonathan Repple, MD, professor of predictive psychiatry at the University of Frankfurt, Germany, discussed his most recent study presented on a poster at the 35th...
